CFTR-deficient pigs display alterations of bone microarchitecture and composition at birth

Julien Braux1, Marie-Laure Jourdain1, Christine Guillaume1

  • 1Université de Reims Champagne Ardenne, BIOS EA 4691, Biomatériaux et Inflammation en site osseux, SFR CAP-Santé (FED 4231), 1, Avenue du Maréchal Juin, 51097 Reims, France.

Insights

Loss of cystic fibrosis transmembrane conductance regulator (CFTR) function in pigs alters bone microstructure and composition at birth. This suggests bone defects in cystic fibrosis may be a primary issue, not secondary to inflammation.

Area of Science:

  • Bone biology
  • Genetics
  • Physiology

Background:

  • Cystic fibrosis (CF) is caused by absent or dysfunctional cystic fibrosis transmembrane conductance regulator (CFTR).
  • CF patients exhibit bone issues like osteopenia, even before severe lung disease, hinting at developmental origins.
  • Studying CFTR's role in bone is challenging in humans, necessitating animal models.

Purpose of the Study:

  • To investigate the direct impact of CFTR absence on bone development and composition.
  • To compare bone parameters in newborn CFTR-deficient pigs versus wild-type littermates.

Main Methods:

  • Micro-computed tomography (μCT) was used to assess femoral cortical and trabecular bone morphology and microstructure.
  • Raman microspectroscopy analyzed the chemical composition of the bone.
  • Studies were conducted on both male and female CFTR knockout (CFTR-/-) pigs and their wild-type (WT) littermates.

Main Results:

  • CFTR-/- pigs exhibited altered bone integrity, with reduced cortical thickness and increased cortical porosity compared to WT pigs.
  • Trabecular bone in CFTR-/- pigs showed increased chemical heterogeneity, a higher carbonate/phosphate ratio, and enhanced mineral crystallinity.
  • These bone composition changes were observed in both male and female newborn pigs.

Conclusions:

  • The absence of CFTR directly impacts bone composition and metabolism in newborn pigs.
  • These findings suggest that bone defects in cystic fibrosis patients may be a primary consequence of CFTR dysfunction, rather than secondary to chronic inflammation or infection.
Abstract

Related Concept Videos

Bone Formation by Endochondral Ossification01:24

Bone Formation by Endochondral Ossification

Bone formation, or ossification, begins around the sixth to seventh week of embryonic development. Most bones develop from a cartilaginous template through the process of endochondral ossification. Cartilage formation begins when clusters of mesenchymal cells differentiate into chondrocytes. These chondrocytes proliferate rapidly and secrete an extracellular matrix that becomes encased in a membrane called the perichondrium. The resulting cartilage model provides a template that resembles the...
8.0K
Bone Formation by Intramembranous Ossification01:29

Bone Formation by Intramembranous Ossification

Intramembranous ossification is one of the two processes involved in the development of bones within an embryo. The flat bones of the face, most of the cranial bones, and the clavicles are formed via this process. During intramembranous ossification, the bones develop directly from sheets of undifferentiated mesenchymal connective tissue.
The process begins when mesenchymal cells in the embryonic skeleton gather together and differentiate into osteogenic cells, which then develop into ...
9.9K
Bone Disorders01:29

Bone Disorders

Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
5.0K